Chemomab Therapeutics Ltd (CMMB)
0.631
-0.03
(-4.25%)
USD |
NASDAQ |
Apr 26, 15:51
Chemomab Therapeutics 1 Year Total Returns (Daily): -57.48% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -57.48% |
April 24, 2024 | -57.05% |
April 23, 2024 | -58.64% |
April 22, 2024 | -59.27% |
April 19, 2024 | -59.52% |
April 18, 2024 | -57.83% |
April 17, 2024 | -63.80% |
April 16, 2024 | -59.22% |
April 15, 2024 | -54.94% |
April 12, 2024 | -52.48% |
April 11, 2024 | -51.90% |
April 10, 2024 | -49.36% |
April 09, 2024 | -44.37% |
April 08, 2024 | -44.32% |
April 05, 2024 | -44.06% |
April 04, 2024 | -47.30% |
April 03, 2024 | -46.20% |
April 02, 2024 | -52.08% |
April 01, 2024 | -51.50% |
March 28, 2024 | -51.31% |
March 27, 2024 | -52.47% |
March 26, 2024 | -53.48% |
March 25, 2024 | -54.84% |
March 22, 2024 | -49.67% |
March 21, 2024 | -51.30% |
Date | Value |
---|---|
March 20, 2024 | -47.05% |
March 19, 2024 | -48.10% |
March 18, 2024 | -45.88% |
March 15, 2024 | -47.07% |
March 14, 2024 | -44.36% |
March 13, 2024 | -42.78% |
March 12, 2024 | -41.89% |
March 11, 2024 | -44.26% |
March 08, 2024 | -52.16% |
March 07, 2024 | -50.00% |
March 06, 2024 | -56.15% |
March 05, 2024 | -61.49% |
March 04, 2024 | -60.98% |
March 01, 2024 | -63.54% |
February 29, 2024 | -55.81% |
February 28, 2024 | -56.32% |
February 27, 2024 | -60.37% |
February 26, 2024 | -61.27% |
February 23, 2024 | -57.35% |
February 22, 2024 | -62.59% |
February 21, 2024 | -70.48% |
February 20, 2024 | -65.82% |
February 16, 2024 | -68.03% |
February 15, 2024 | -69.65% |
February 14, 2024 | -71.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.33%
Minimum
Feb 10 2022
622.8%
Maximum
Mar 16 2021
-39.65%
Average
-64.26%
Median
1 Year Total Returns (Daily) Benchmarks
Compugen Ltd | 216.7% |
Pluri Inc | -37.50% |
BioLine Rx Ltd | -48.63% |
Can Fite Biofarma Ltd | 7.87% |
BiomX Inc | 34.29% |